Page 20 - Revista Científica Biofar
P. 20
8
1
18 B I O F A R – C I E N T I F I C A
BIOFAR – CIENTIFICA
41. Fernandez-Cuenca F., Pascual A., Ribera 49. Mugnier P.D., Poirel L., Naas T., et al.
A. et al. Clonal diversity and Worldwide dissemination of the
antimicrobial susceptibility of blaOXA-23 carbapenemase gene of
Acinetobacter baumannii isolated in Acinetobacter baumannii . Emerg Infect
Spain. A nationwide multicenter study: Dis. 2010; 16(1): 35-40.
GEIH-ab project (2000). Enferm Infecc 50. Scaife W., Young H.K., Paton R.H. et al.
Microbiol Clin. 2004.22: 267-71. Transferable imipenem-resistance in
42. Gonzalez G., Mella S., Zemelman R. et Acinetobacter species from a clinical
al. Integrons and resistance gene source. J Antimicrob Chemother.
cassettes: Structure and role against 1995.36: 585-6.
antimicrobials. Rev Med Chil. 2004.132: 51. Chen T.L., Lee Y.T., Kuo S.C. et al.
619-26. Emergence and distribution of plasmids
43. Ribera A., Vila J., Fernandez-Cuenca F. bearing the bla OXA-51-like gene with
et al. Type 1 integrons in an upstream ISAba1 in carbapenem-
epidemiologically unrelated Acineto- resistant Acinetobacter baumannii
bacter baumannii isolates collected at isolates in Taiwan. Antimicrob Agents
Spanish hospitals. Antimicrob Agents Chemother. 2010.54: 4575-81.
Chemother. 2004.48: 364-5. 52. Peleg A.Y., Seifert H., Paterson D.L.
44. Nemec A., Janda L., Melter O. et al. Acinetobacter baumannii: Emergence of
Genotypic and phenotypic similarity of a successful pathogen. Clin Microbiol
multiresistant Acinetobacter baumannii Rev. 2008.21: 538-82.
isolates in the Czech Republic. J Med 53. Quinteira S., Grosso F., Ramos H. et al.
Microbiol. 1999.48: 287-96. Molecular epidemiology of imipenem-
45. Heritier C., Dubouix A., Poirel L. et al. resistant Acinetobacter haemolyticus and
A nosocomial outbreak of Acinetobacter Acinetobacter baumannii isolates
baumannii isolates expressing the carrying plasmid-mediated OXA-40
carbapenem-hydrolysing oxacillinase from a Portuguese hospital. Antimicrob
OXA-58. J Antimicrob Chemother. Agents Chemother. 2007.51: 3465-6.
2005.55: 115-8. 54. Catalano M., Quelle L.S., Jeric P.E. et al.
46. Wang H., Guo P., Sun H. et al. Molecular Survival of Acinetobacter baumannii on
epidemiology of clinical isolates of bed rails during an outbreak and during
carbapenem-resistant Acinetobacter spp. sporadic cases. J Hosp Infect. 1999.42:
from Chinese hospitals. Antimicrob 27-35.
Agents Chemother. 2007.51: 4022-8. 55. Rodriguez C.H., Bombicino K.,
47. Zarrilli R., Vitale D., Di Popolo A. et al. Granados G. et al. Microbiological and
A plasmid-borne bla OXA-58 gene epidemiological evaluation of
confers imipenem resistance to carbapenem-resistant Acinetobacter
Acinetobacter baumannii isolates from a baumannii clones isolated at an intensive
Lebanese hospital. Antimicrob Agents care unit of a university hospital in
Chemother. 2008.52: 4115-20. Buenos Aires city. Rev Argent
48. Iacono M., Villa L., Fortini D. et al. Microbiol. 2009.41: 151-5.
Whole-genome pyrosequencing of an 56. Van Dessel H., Dijkshoorn L., van der
epidemic multidrug - resistant Reijden T. et al. Identification of a new
Acinetobacter baumannii strain belonging geographically widespread multiresistant
to the European clone II group. Acinetobacter baumannii clone from
Antimicrob Agents Chemother. 2008.52: European hospitals. Res Microbiol.
2616-25. 2004.155: 105-12.